Skip to main content
See every side of every news story
Published • loading... • Updated

Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results

Summary by Medical Daily
Merck and Moderna are preparing to seek FDA approval for a personalized mRNA melanoma vaccine used with Keytruda. No filing date has been set.

2 Articles

Lean Right

In Russia, about 15 mRNA vasectomies against melanoma have been produced, as reported by the scientific director of the N. F. Gamalei Centre, Alexander Ginzburg. He said that two patients in Russia had already introduced a personalized MRNA vaccine against melanoma. "Personal MRNA vaccine against melanoma has already been introduced to two patients, up to 15 such vaccines have been produced," quote Ginsburg Press Service of the Bashkir State Med…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medical Daily broke the news on Tuesday, October 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal